U.S. stock index futures retreated on Tuesday as lawmakers geared up to debate a coronavirus relief deal to limit the economic damage from the pandemic, with investors also keeping an eye on quarterly earnings reports from Pfizer and McDonald's.
FILE PHOTO: The Wall Street sign is pictured at the New York Stock exchange in the Manhattan borough of New York City, New York, U.S., March 9, 2020. REUTERS/Carlo Allegri
- U.S. stock index futures retreated on Tuesday as lawmakers geared up to debate a coronavirus relief deal to limit the economic damage from the pandemic, with investors also keeping an eye on quarterly earnings reports from Pfizer and McDonald’s. Senate Republicans announced on Monday a $1 trillion aid package hammered out with the White House — four days before millions of Americans lose unemployment benefits — but the proposal sparked immediate opposition from both Democrats and Republicans.
Hopes of more government stimulus helped Wall Street’s main indexes close higher on Monday, with traders also tracking corporate America’s forecasts for a business recovery and signs of progress in developing a COVID-19 vaccine.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Stocks making the biggest moves after hours: Pfizer, F5 Networks, Virgin Galactic and moreSee which stocks are posting big moves after the bell.
続きを読む »
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
続きを読む »
Moderna, Pfizer Coronavirus Vaccines Begin Final-Stage TestingTwo of the most advanced experimental vaccines entered the pivotal phase of their studies, with the first subjects receiving doses of Moderna vaccine and Pfizer preparing to inject participants in its trial.
続きを読む »
Pfizer, BioNTech could submit vaccine for approval by Oct – latest updatesPfizer, BioNTech could submit vaccine for approval by October. Other Covid19 updates: 🌍 Virus-linked hunger tied to 10,000 child deaths a month 🇧🇴 Bolivian prisoners riot over virus exposure 🇰🇪 Kenya extends lockdown by 30 days More here:
続きを読む »
Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidateGerman biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
続きを読む »
Pfizer Sales Fall as Company Races Toward Covid-19 VaccinePfizer reported growth in its biopharma division in the latest quarter, but overall sales fell amid increased competition in its generic-drug business.
続きを読む »